SpicyIP Interview: Justice Prabha Sridevan on Evolving Roles of Expert Evidence in Indian IP Litigation

/ By / Others, Patent

Recently, I had the privilege of interviewing Justice Sridevan as part of my doctoral research and I found it to be exceptionally insightful. She shared several pertinent points on issues concerning expert evidence in IP litigations and what she thinks is the best way forward for the Indian Courts vis a vis engaging experts in IP matters. As she kindly agreed to my request to also publish this as a blogpost, I am happy to share this with our readers. […]

SpicyIP Interview: Justice Prabha Sridevan on Evolving Roles of Expert Evidence in Indian IP Litigation Read More »

SpicyIP Tidbit: Delhi Police Authorized to Issue Takedown Orders for Unlawful Content

/ By / Copyright

[This post has been authored by SpicyIP intern Aditi Agrawal. Aditi is a final-year B.A., LL.B (IPR Hons.) student at The ICFAI University, Dehradun. Her previous posts can be accessed here.] On 26th December 2024, the Delhi Government issued a gazette notification (F. No. 11/24/2024/HP-II/4236-4244), designating Delhi Police as the nodal agency for regulating digital content hosted or published on intermediary platforms in the National Capital Territory of Delhi. This move, reported earlier on January 9 by Aditi Agrawal in

SpicyIP Tidbit: Delhi Police Authorized to Issue Takedown Orders for Unlawful Content Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (January 20 – January 26)

/ By / Copyright, Others, Patent, Trademark

(This post has been co-authored with SpicyIP Intern Aditi Agrawal) Here is our recap of last week’s top IP developments including summary of the post on the analysis of Delhi HC’s judgment in Master Arnesh Shaw, a letter by MP Haris Beeran to the Government urging to invoke Section 100, Patents Act for rare disease medicine, and the statutory duty under Section 151 of Patents Act. This and a lot more in this week’s SpicyIP Weekly Review. Anything we are

SpicyIP Weekly Review (January 20 – January 26) Read More »

Do Indian Scientists Need to Worry about CRISPR Licences?

/ By / Patent

In the wake of Anurag Chaurasia’s (paywalled) Nature piece cautioning Indian scientists to conduct due diligence before using CRISPR gene editing tools, Prashant Reddy T looks closely at the patent issues raised by Chaurasia in his paper. Prashant Reddy T is one of our most prolific bloggers (his posts can be accessed here). He is also the co-author of two books- “Create, Copy, Disrupt: India’s Intellectual Property Dilemmas” (OUP, 2017) and “The Truth Pill: The Myth of Drug Regulation in India”

Do Indian Scientists Need to Worry about CRISPR Licences? Read More »

The Screenwriters Rights Association of India (SRAI) is registered, but what is a Script: A Dramatic or a Literary work?

/ By / Others

“Overlap”—such an interesting word, isn’t it? It’s everywhere. Our ideas overlap, our works overlap, our words overlap, and even our feelings and emotions. And yes, so do our laws and their intricate concepts. But why am I talking about overlaps? While reading the news about the Screenwriters Rights Association of India (SRAI) officially registering as a Copyright Society (Reg. No. CS/06/2024), the word clung to my mind. Especially when a close friend (who prefers to remain anonymous) pointed out the

The Screenwriters Rights Association of India (SRAI) is registered, but what is a Script: A Dramatic or a Literary work? Read More »

Call for Registration: “Art Meets Law” Conference by Centre for Art and Law Initiatives in Collaboration with RFKN Legal and the German Institute for Art and Law (January 31)

/ By / Event

The Centre for Art and Law Initiatives in collaboration with RFKN Legal and the German Institute for Art and Law (IFKUR) is hosting its Inaugural Conference- “Art Meets Law” on 31st January 2025, at the India International Centre, New Delhi. Please read below for their announcement. Call for Registration: “Art Meets Law” Conference by Centre for Art and Law Initiatives in Collaboration with RFKN Legal and the German Institute for Art and Law (January 31) The Centre for Art and

Call for Registration: “Art Meets Law” Conference by Centre for Art and Law Initiatives in Collaboration with RFKN Legal and the German Institute for Art and Law (January 31) Read More »

Who “Notices” When Patents Are Revoked/Invalidated? Examining Section 151, Patents Act

/ By / Patent

Following up on his discussion of Macleods Pharmaceuticals v. The Controller, SpicyIP Intern Bharathwaj Ramakrishnan further discusses the statutory duty under Section 151 of the Patents Act to record revocations or invalidations – and has trouble finding this! Bharathwaj is a 3rd year LLB Student at RGSOIPL, IIT Kharagpur, and loves books and IP. His previous posts can be accessed here. by Bharathwaj Ramakrishnan In my previous post, I discussed Macleods Pharmaceuticals Ltd v. The Controller of Patents & Anr,

Who “Notices” When Patents Are Revoked/Invalidated? Examining Section 151, Patents Act Read More »

Brace yourself, it’s getting a bit procedural: Analysing Macleods Pharmaceuticals Ltd v. The Controller of Patents & Anr.

/ By / Patent

The Delhi HC in Macleods Pharmaceuticals Ltd v. The Controller of Patents & Anr. answered whether a revocation petition is sustainable if the defence of invalidity has been taken in an infringement suit and whether a revocation petition is sustainable when the patent has expired. SpicyIP Intern Bharathwaj Ramakrishnan explains the Court’s finding in its judgment in Macleods. Bharathwaj is a 3rd year LLB Student at RGSOIPL, IIT Kharagpur, and loves books and IP. His previous posts can be accessed

Brace yourself, it’s getting a bit procedural: Analysing Macleods Pharmaceuticals Ltd v. The Controller of Patents & Anr. Read More »

A Rare Invocation for a Rare Disease?: Government Urged to Invoke Section 100, Patents Act for Rare Disease Medicine

/ By / Patent

Rajya Sabha MP Haris Beeran wrote to the Minister of Health and Family Welfare on December 20, 2024, urging the Central Government to invoke Section 100 (1) of the Patents Act with respect to local production of the rare disease Spinal Muscular Atrophy (SMA) treating drug Risdiplam. SMA is a genetic disease affecting the nerve cells that control voluntary muscle movement. SMA incidence in India is one in 10,000 live-born babies. Section 100 empowers the central government to use, or

A Rare Invocation for a Rare Disease?: Government Urged to Invoke Section 100, Patents Act for Rare Disease Medicine Read More »

Taking a Look at the Delhi High Court’s Ambitious (Yet Necessary?) Directives in Master Arnesh Shaw v. Union of India

/ By / Others

[This post is authored by Sunidhi Das. Sunidhi is a second year student at NLSIU, Bangalore and is very enthusiastic about IP law and policy. Also a big thanks to Bharathwaj Ramakrishnan, Md. Sabeeh Ahmad, Praharsh, and Swaraj Paul Barooah for their input. Long post ahead.] On October 4, 2024, the Delhi High Court issued a judgment in Master Arnesh Shaw v. Union of India, directing the Union Government to allocate ₹974 crore to the National Fund for Rare Diseases

Taking a Look at the Delhi High Court’s Ambitious (Yet Necessary?) Directives in Master Arnesh Shaw v. Union of India Read More »

Scroll to Top